We are live on ! Find out more
SM

Sabby Management Portfolio holdings

AUM $45.1M
1-Year Est. Return 74.25%
This Fund
S&P 500
This Quarter Est. Return
-13.57%
1 Year Est. Return
-74.25%
3 Year Est. Return
-95.86%
5 Year Est. Return
-99.36%
10 Year Est. Return
-99.46%
AUM
$241M
AUM Growth
-$120M
Cap. Flow
-$12M
Cap. Flow %
-5%
Top 10 Hldgs %
81.75%
Holding
117
New
44
Increased
16
Reduced
22
Closed
31

Top Buys

Rank Stock Value
1
XLV icon
State Street Health Care Select Sector SPDR ETF
XLV
+$3.34M
2
ENLV icon
Enlivex Ltd
ENLV
+$3.28M
3
BXRX
Baudax Bio, Inc. Common Stock
BXRX
+$2.52M
4
NOVN
Novan, Inc. Common Stock
NOVN
+$2.52M
5
OTLK icon
Outlook Therapeutics
OTLK
+$2.36M

Top Sells

Rank Stock Value
1
TRAW icon
Traws Pharma
TRAW
+$3.35M
2
GLD icon
SPDR Gold Trust
GLD
+$2.92M
3
HIND
Vyome Holdings
HIND
+$1.31M
4
GNPX icon
Genprex
GNPX
+$1.03M
5
PAVMZ
PAVmed Inc. Series Z Warrant
PAVMZ
+$891K

Sector Composition

Rank Sector Weight
1 Healthcare 7.26%
2 Technology 0.29%
3 Financials 0.15%
4 Consumer Discretionary 0.04%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLV icon
1
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$51.8M 21.55%
+5,853
New +$569K
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$38.7M 16.07%
1,500
-4,000
-73% -$1.22M
OEF icon
3
PUT
iShares S&P 100 ETF
OEF
$19.8B
$30.5M 12.66%
+2,700
New +$372K
GLD icon
4
PUT
SPDR Gold Trust
GLD
$131B
$20.7M 8.59%
1,396
-342
-20% -$50.9K
GLD icon
5
CALL
SPDR Gold Trust
GLD
$131B
$14.4M 5.99%
974
-96
-9% -$14.3K
XNTK icon
6
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2B
$13.7M 5.69%
1,769
+1,269
+254% +$105K
XLV icon
7
CALL
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$8.86M 3.68%
+1,000
New +$97.2K
SPY icon
8
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$8.61M 3.58%
334
-1,282
-79% -$391K
OEF icon
9
CALL
iShares S&P 100 ETF
OEF
$19.8B
$6.44M 2.68%
574
-724
-56% -$99.8K
XLV icon
10
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$3.05M 1.27%
+34,410
New +$3.34M
GILD icon
11
CALL
Gilead Sciences
GILD
$167B
$2.76M 1.15%
+2,166
New +$150K
GLD icon
12
SPDR Gold Trust
GLD
$131B
$2.65M 1.1%
17,934
-19,616
-52% -$2.92M
CVM.WS
13
PUT
DELISTED
Cel-Sci Corp Series S
CVM.WS
$2.6M 1.08%
+2,252
New +$2.6M
AVEO
14
PUT
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.41M 1%
10,248
+9,163
+845% +$45.5K
NOVN
15
DELISTED
Novan, Inc. Common Stock
NOVN
$2.11M 0.88%
+443,816
New +$2.52M
ENLV icon
16
Enlivex Ltd
ENLV
$37.7M
$2.09M 0.87%
+29,712
New +$3.28M
OTLK icon
17
Outlook Therapeutics
OTLK
$169M
$1.94M 0.81%
161,617
+142,170
+731% +$2.36M
BCLI
18
PUT
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$1.88M 0.78%
269
+130
+94% +$10.1K
AVEO
19
CALL
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.53M 0.64%
4,229
+3,866
+1,065% +$19.2K
ODT
20
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$1.35M 0.56%
48,988
-4,851
-9% -$141K
KYNB
21
PUT
Kyntra Bio
KYNB
$28.2M
$1.25M 0.52%
+14
New +$13.9K
ODT
22
PUT
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$1.23M 0.51%
+445
New +$13K
TRIL
23
DELISTED
Trillium Therapeutics Inc.
TRIL
$1.16M 0.48%
+287,906
New +$1.09M
OIL
24
CALL
DELISTED
iPath Series B S&P GSCI Crude Oil ETN
OIL
$1.16M 0.48%
+250
New +$2.36K
PAVMZ
25
DELISTED
PAVmed Inc. Series Z Warrant
PAVMZ
$962K 0.4%
1,035,396
-1,117,323
-52% -$891K
1
2 3 4 5

Similar funds

CG
Circumference Group Little Rock, Arkansas $44.6M AUM 5.21% 1-Year Est. Return
OC
Optimas Capital Central, Hong Kong $44.5M AUM 24.43% 1-Year Est. Return
ICCON
Investment Counsel Company of Nevada Las Vegas, Nevada $44.5M AUM 21.97% 1-Year Est. Return
PCM
Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return
CAS
CTC Alternative Strategies Chicago, Illinois $44M AUM 43.15% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
CTC
Corundum Trust Company Sioux Falls, South Dakota $43.8M AUM 20.07% 1-Year Est. Return

Sabby Management's Q1 2020 Portfolio in Review

As of Q1 2020, Sabby Management held 117 positions worth $241M, down 33% from $361M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Sabby Management withdrew a net $12M in Q1 2020, closing 31 positions and reducing 22 holdings. Its most notable exit was Traws Pharma, an estimated $3.35M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.3% of assets, up from 5.4% a quarter earlier, followed by Technology and Financials.

Against the trend, Sabby Management opened a new position in State Street Health Care Select Sector SPDR ETF worth $3.05M.

  • Sabby Management's largest Q1 2020 buy was State Street Health Care Select Sector SPDR ETF: 34,410 shares worth $3.05M.
  • Sabby Management added most to Outlook Therapeutics in Q1 2020, an estimated $2.36M increase.
  • Sabby Management's biggest Q1 2020 reduction was SPDR Gold Trust, cutting an estimated $2.92M.
  • Sabby Management fully exited Traws Pharma in Q1 2020, selling an estimated $3.35M.
  • Sabby Management's ten largest holdings make up 82% of its $241M portfolio in Q1 2020.
  • Sabby Management opened 44 new positions and closed 31 in Q1 2020.
  • Sabby Management's portfolio value fell 33% quarter-over-quarter to $241M.

Based on Sabby Management's 13F filing for Q1 2020, filed 15 May 2020.